Bronchofen Contraindications

As chlorpheniramine maleate may cause drowsiness and sedation, patients must avoid engaging in activities which require mental alertness.
(Phenylephrine-Chlorpheniramine) Bronchofen should not be taken by asthmatic patients or by patients with known hypersensitivity to any of the active ingredients. It should not be administered concurrently with monoamine oxidase inhibitors or within 14 days of stopping such treatment.
(Phenylephrine-Chlorpheniramine) Bronchofen is contraindicated in patients with history of hypersensitivity to the active ingredients, in coronary artery disease, hypertension, hyperthyroidism, hyperexcitability, acute asthma attacks, tumor of the adrenal gland (pheochromocytoma), narrow-angle glaucoma and severe liver function impairment. It should be used with great caution by individuals with history of asthma, high blood pressure, diabetes, thyroid disease, glaucoma and enlargement of the prostate gland.
Phenylephrine should be given with great caution in patients with diabetes mellitus. Safety in pregnancy and lactation has not been established.